Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Akers Biosciences Company Profile (NASDAQ:AKER)

Consensus Ratings for Akers Biosciences (NASDAQ:AKER) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $11.00 (165.06% upside)

Analysts' Ratings History for Akers Biosciences (NASDAQ:AKER)
Show:
DateFirmActionRatingPrice TargetDetailsShare
6/9/2014AegisInitiated CoverageBuy$11.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 9/23/2012 forward)
Discuss Akers Biosciences